These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 30153147)

  • 1. Central Nervous System Myelomatosis Delineated by High-Resolution Brain Images From Fully Digital 18F-FDG PET.
    Bahloul A; Perrin M; Amlal S; Marie PY; Verger A
    Clin Nucl Med; 2018 Oct; 43(10):e372-e373. PubMed ID: 30153147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuro-Myelomatosis of the Brachial Plexus - An Unusual Site of Disease Visualized by FDG-PET/CT: A Case Report.
    Fukunaga H; Mutoh T; Tatewaki Y; Shimomura H; Totsune T; Terao C; Miyazawa H; Taki Y
    Am J Case Rep; 2017 May; 18():478-481. PubMed ID: 28458390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PET/CT and MR imaging of central nervous system myelomatosis.
    Nguyen BD; Ram PC; Roarke MC
    Clin Nucl Med; 2010 Dec; 35(12):953-5. PubMed ID: 21206230
    [No Abstract]   [Full Text] [Related]  

  • 4. High-Resolution Brain 18F-FDG Images Provided by Fully Digital PET.
    Salvadori J; Perrin M; Marie PY; Imbert L; Verger A
    Clin Nucl Med; 2019 Apr; 44(4):301-302. PubMed ID: 30789394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced MRI and 18F-FDG PET/CT Findings of Primary Central Nervous System Lymphoma Mimicking Encephalitis.
    Ge J; Zuo C; Guan Y; Zhao G
    Clin Nucl Med; 2016 Oct; 41(10):e436-8. PubMed ID: 27355853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. F-18 FDG uptake of bone marrow on PET/CT scan: it's correlation with CD38/CD138 expressing myeloma cells in bone marrow of patients with multiple myeloma.
    Ak I; Gulbas Z
    Ann Hematol; 2011 Jan; 90(1):81-7. PubMed ID: 20690019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value of precise localization of recurrent multiple myeloma with F-18 FDG PET/CT.
    Cholewinski W; Castellon I; Raphael B; Heiba SI
    Clin Nucl Med; 2009 Jan; 34(1):1-3. PubMed ID: 19092371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of 18F-FDG PET/CT in the assessment of bone involvement in newly diagnosed multiple myeloma: preliminary results.
    Nanni C; Zamagni E; Farsad M; Castellucci P; Tosi P; Cangini D; Salizzoni E; Canini R; Cavo M; Fanti S
    Eur J Nucl Med Mol Imaging; 2006 May; 33(5):525-31. PubMed ID: 16453155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative and Visual Characteristics of Primary Central Nervous System Lymphoma on
    Liu D; Kong Z; Wang Y; Chen W; Wang Y; Chen W; Liu L; Dang Y; Ma W; Wang Y; Cheng X
    Interdiscip Sci; 2019 Jun; 11(2):300-306. PubMed ID: 31264053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative study of fluorodeoxyglucose positron emission tomography and magnetic resonance imaging for the detection of spinal bone marrow infiltration in untreated patients with multiple myeloma.
    Hur J; Yoon CS; Ryu YH; Yun MJ; Suh JS
    Acta Radiol; 2008 May; 49(4):427-35. PubMed ID: 18415787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lesions of multiple myeloma adjacent to the skull are better visualized on F-18 fluoroethyldimethyl-2-hydroxyethylammonium (FECH) PET images than on F-18 FDG PET images.
    Cheng X; Cui R; Li F; Zhuang H
    Clin Nucl Med; 2011 Oct; 36(10):912-4. PubMed ID: 21892045
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical value of 18F-FDG-PET and 11C-MET-PET in patients with plasma cell malignancy].
    Kobayashi M; Yamashita K; Takaori-Kondo A
    Nihon Rinsho; 2015 Jan; 73(1):74-9. PubMed ID: 25626308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 18F-FDG PET/CT in primary central nervous system lymphoma in HIV-negative patients.
    Karantanis D; O'eill BP; Subramaniam RM; Witte RJ; Mullan BP; Nathan MA; Lowe VJ; Peller PJ; Wiseman GA
    Nucl Med Commun; 2007 Nov; 28(11):834-41. PubMed ID: 17901765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The value of fluorodeoxyglucose positron emission tomography in multiple myeloma].
    Adam Z; Bolcák K; Stanícek J; Pour L; Hájek R; Krejcí M; Prásek J; Neubauer J; Mareschova Y; Vorlícek J
    Vnitr Lek; 2006 Mar; 52(3):207-14. PubMed ID: 16722151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment response evaluation with
    Sachpekidis C; Hillengass J; Goldschmidt H; Wagner B; Haberkorn U; Kopka K; Dimitrakopoulou-Strauss A
    Eur J Nucl Med Mol Imaging; 2017 Jan; 44(1):50-62. PubMed ID: 27573638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic tumor volume assessed by 18F-FDG PET/CT for the prediction of outcome in patients with multiple myeloma.
    Fonti R; Larobina M; Del Vecchio S; De Luca S; Fabbricini R; Catalano L; Pane F; Salvatore M; Pace L
    J Nucl Med; 2012 Dec; 53(12):1829-35. PubMed ID: 23071351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [18F-FDG PET/CT and 99mTc-MIBI scintigraphy in evaluation of patients with multiple myeloma and monoclonal gammopathy of unknown significance: comparison of methods].
    Myslivecek M; Bacovský J; Scudla V; Koranda P; Minarík J; Buriánková E; Formánek R; Zapletalová J
    Klin Onkol; 2010; 23(5):325-31. PubMed ID: 21061682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of
    Cavo M; Terpos E; Nanni C; Moreau P; Lentzsch S; Zweegman S; Hillengass J; Engelhardt M; Usmani SZ; Vesole DH; San-Miguel J; Kumar SK; Richardson PG; Mikhael JR; da Costa FL; Dimopoulos MA; Zingaretti C; Abildgaard N; Goldschmidt H; Orlowski RZ; Chng WJ; Einsele H; Lonial S; Barlogie B; Anderson KC; Rajkumar SV; Durie BGM; Zamagni E
    Lancet Oncol; 2017 Apr; 18(4):e206-e217. PubMed ID: 28368259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 18F-fluorocholine versus 18F-fluorodeoxyglucose for PET/CT imaging in patients with suspected relapsing or progressive multiple myeloma: a pilot study.
    Cassou-Mounat T; Balogova S; Nataf V; Calzada M; Huchet V; Kerrou K; Devaux JY; Mohty M; Talbot JN; Garderet L
    Eur J Nucl Med Mol Imaging; 2016 Oct; 43(11):1995-2004. PubMed ID: 27121691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of PET/CT in treatment response evaluation and recurrence prediction in patients with newly-diagnosed multiple myeloma.
    Li Y; Liu J; Huang B; Chen M; Diao X; Li J
    Oncotarget; 2017 Apr; 8(15):25637-25649. PubMed ID: 27556189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.